VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1703338
Sex: U
Age: 41
State: NC

Vax Date: 07/30/2021
Onset Date: 07/30/2021
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Received Expired Dose; Initial Report Received on 30-Jul-2021 A certified medical assistant reported that a 41 year-old female (race and ethnicity not provided) received an expired dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization. Medical history included previous vaccination for hepatitis B (vaccine not specified) but there was no titer. Therefore, a new series of hepatitis B vaccine was initiated. The patient was reported to be well and healthy. No relevant concomitant medications were reported. On 30-Jul-2021, the patient received an expired dose of HEPLISAV-B (Lot # 933621, expiration date 26-Jul-2021, NDC # 4352800301, serial number not provided) in the left deltoid. There were no adverse reactions reported. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.

Other Meds:

Current Illness:

ID: 1703339
Sex: U
Age: 27
State: LA

Vax Date: 08/03/2021
Onset Date: 08/03/2021
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Expired Dose of Heplisav-B was Given; Initial Report Received on 04-Aug-2021 A pharmacist reported that a 27 year-old female (race and ethnicity not provided) received an expired dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization. No medical history was reported other than an allergy to Bactrim. No relevant concomitant medications were reported. On 03-Aug-2021, the patient received an expired dose of HEPLISAV-B (Lot # 933622, expiration date 01-Aug-2021, NDC # 43528000301, and serial number not provided). The route and site of injection were not provided. No additional information was provided. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.

Other Meds:

Current Illness:

ID: 1703340
Sex: U
Age:
State: VA

Vax Date: 08/03/2021
Onset Date: 08/03/2021
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Expired Dose of Heplisav-B was Given; Initial Report Received on 09-Aug-2021 A pharmacist reported that a 19 year-old female (race and ethnicity not provided) received an expired dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization. Relevant medical history was not reported. Relevant concomitant medications were unknown. On 03-Aug-2021, the patient received an expired dose of HEPLISAV-B (Lot # 933094, expiration date 17-Apr-2021, NDC # 43528-003-05, and serial # 368019294006) to the left deltoid at a pharmacy. This was the first dose of the series. No adverse effects were reported. At the time of reporting, no additional information was provided. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.

Other Meds:

Current Illness:

ID: 1703341
Sex: U
Age: 60
State: WA

Vax Date: 08/11/2021
Onset Date: 08/11/2021
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Expired Dose of Heplisav-B was Given; Initial Report Received on 13-Aug-2021 A certified medical assistant reported that a 60 year-old female (race and ethnicity not provided) received an expired dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization. No relevant medical history was reported. No relevant concomitant medications were reported. On 11-Aug-2021, the patient received a dose of HEPLISAV-B (Lot # 933624, expiration date 10-Aug-2021, serial number 178642652628 and NDC # not reported) in the left deltoid. No adverse effects were reported. No additional information was reported. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.

Other Meds:

Current Illness:

ID: 1703342
Sex: U
Age: 26
State: OR

Vax Date: 07/12/2021
Onset Date: 08/13/2021
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Expired Dose of Heplisav-B was Given; Initial Report Received on 13-Aug-2021 A pharmacist reported that a 26 year-old female (race and ethnicity not provided) received an expired dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization. No relevant medical history was reported. The patient was not pregnant. No relevant concomitant medications were reported. On 12-Jul-2021, the patient received the first dose of HEPLISAV-B (Lot #, expiration date, and NDC # not reported). On 13-Aug-2021, the patient received the second dose of HEPLISAV-B (Lot # 933622, expiration date 01-Aug-2021, serial number 597626603178 and NDC # 43528-003-05) in the left deltoid. No adverse effects were reported. No additional information was reported. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.

Other Meds:

Current Illness:

ID: 1703346
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: suspected vaccination failure; shingles/ shingles on brain; coma; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), coma (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown and the outcome of the coma was recovered/resolved. It was unknown if the reporter considered the vaccination failure, coma and shingles to be related to Shingles vaccine. Additional details were provided as follows: The reporter was known to patient. The age at vaccination was not reported. The reporter stated that, the patient received Shingles shot and ended in a coma a couple of years ago for over a month, they said he had shingles on the brain. This case was considered as suspected vaccination failure, since the details regarding the completion of primary vaccination schedule, time to onset for event and laboratory confirmation for shingles were not provided. The case had been linked with US2021AMR190777, reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR190777:same reporter

Other Meds:

Current Illness:

ID: 1703348
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: got the new double shot this year, I have shingles; shingles; burning feeling; nerve pain; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Shingles vaccine (the patient had shingles shot several years ago). On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, less than a year after receiving Shingles vaccine and 8 months after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, burning sensation and nerve pain. On an unknown date, the outcome of the vaccination failure, shingles, burning sensation and nerve pain were unknown. It was unknown if the reporter considered the vaccination failure, shingles, burning sensation and nerve pain to be related to Shingles vaccine and Shingles vaccine. Additional details were provided as follows: The reporter was patient. The age at vaccination was not reported. The reporter stated that he/she had the shingles shot several years ago. Then got the new double shot this year. 8 months later the patient had shingles on the side of foot. The patient went to doctor after about 2 weeks as he/ she thought it was poison ivy until the burning feeling started. Turns out the burning feeling was nerve pain along the nerve running down the side of his/her foot to where the shingles was on the side of foot near toes. The physician confirmed it was shingles and said thankfully the patient got the shot or patient most likely would have had a severe case. The patient was shocked with his diagnosis as shingles was the last thing that would have ever crossed His/her mind because the patient had both the old vaccine and the 2 dose new vaccine. The patient stated that vaccines aren't 100% but offer much greater protection This case was considered as suspected vaccination failure since the details regarding laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1703349
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: got the shot, I have it again/ suspected vaccination failure; I have it again; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included shingles (had shingles 15 years ago). On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: This case was self-reported by the patient. The age at vaccination was not reported. The patient had shingles fifteen years ago and got the shot when it was over. The patient again got shingles after the shot and made doctor's appointment before it got worse. The patient thought he/she was safe. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1703350
Sex: F
Age: 63
State: WV

Vax Date: 07/08/2021
Onset Date: 08/28/2021
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Shingles on 08/28/2021 after first dose; This case was reported by a consumer and described the occurrence of shingles in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included shingles (11 cases of shingles occurred before the vaccine in the past 8 years), shingles (occurred on 9th July 2021, refer case US2021190982) and breast cancer. On 8th July 2021, the patient received the 1st dose of Shingrix. On 28th August 2021, 51 days after receiving Shingrix, the patient experienced shingles. The patient was treated with acyclovir. On an unknown date, the outcome of the shingles was not recovered/not resolved. It was unknown if the reporter considered the shingles to be related to Shingrix. Additional details were provided as follows: This case was reported by the patient herself. The patient mentioned that she had 11 cases of shingles in past 8 years. Out of 11 cases, 4 cases of shingles occurred before Shingrix and that occurred during chemotherapy treatment due to breast cancer. The patient received Shingrix on the right deltoid (National drug code number 58160-0823-11) at the pharmacy. The patient again had a case of shingles last weekend from reporting date and again took a week regimen of acyclovir. The patient had been getting shingles on the same spot each time (upper left hip). The current state of shingles was that they were drying up and becoming smaller in size but were not completely resolved. The reporter gave a consent to follow-up with healthcare professional. However, she did not have a phone/fax number and an email address to healthcare professional. She did not have her personal email address. The reporter consented to follow-up.; Sender's Comments: US-GLAXOSMITHKLINE-US2021190982:Same reporter.

Other Meds:

Current Illness:

ID: 1703352
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: got vaccinated, still got shingles / suspected vaccination failure; shingles/ flares up; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional case details were reported as follows: The reporter was patient's wife. The age at vaccination was not reported. The patient got vaccinated but still got shingles, but just a light case flares up every now and then. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.

Other Meds:

Current Illness:

ID: 1703354
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Got vaccine and broke out with shingles / Suspected vaccination failure; shingles for the 14th time; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient got vaccine and broke out with shingles for the 14th time. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.

Other Meds:

Current Illness:

ID: 1703355
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: 've had them 5 times. Had the shot several years ago and it didn't help/suspected vaccination failure; shingles; seems to keep the pain away; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine and Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles and pain were recovering/resolving. It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine. Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient had them 5 times and had the shot several years ago and it did not help, refer case US2021AMR191936. The patient had the new shot and improved that which the patient had a reaction to. The patient said the best thing was, the patient had found to use when you first feel shingles starting was to put blue kote on them. It seems to keep the pain away and helps them heal quicker, blue kote worked for the patient. No contact details were available.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR191936:same patient same reporter

Other Meds:

Current Illness:

ID: 1703356
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: has had them since getting the shot / Suspected vaccination failure; has had them over 40 times; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional case details were reported as follows: The reporter was patient's friend. The age at vaccination was not reported. The patient has had shingles over 40 times since getting the shot. The reporter would take his or her chances of getting them again without the shot. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.

Other Meds:

Current Illness:

ID: 1703358
Sex: M
Age:
State:

Vax Date: 08/28/2021
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Stomach pain; Diarrhea; Tiredness; Weakness; This case was reported by a consumer Shingrix GSK and described the occurrence of stomach pain in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On 28th August 2021, the patient received Shingrix. On an unknown date, less than 2 weeks after receiving Shingrix, the patient experienced stomach pain, diarrhea, tiredness and weakness. On an unknown date, the outcome of the stomach pain, diarrhea, tiredness and weakness were not recovered/not resolved. It was unknown if the reporter considered the stomach pain, diarrhea, tiredness and weakness to be related to Shingrix. Additional details were provided as follows: The reporter was wife of the patient. The age at vaccination was not reported. The patient got the Shingrix vaccine on 28th August 2921 and since then he had been experiencing stomach pain, diarrhea and tiredness/weakness off and on. Note: Discrepancy is present regarding year of the vaccination was reported as 2921 but has been conservatively added as 2021 as 2921 is a future date and seems to be typo error, hence considered as 28th August 2021.

Other Meds:

Current Illness:

ID: 1703359
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: got the shot a few years ago. Shortly afterward I got shingles / suspected vaccination failure; shingles went into my eye; nearly blind; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), ophthalmic herpes zoster (serious criteria GSK medically significant) and blindness (serious criteria GSK medically significant). On an unknown date, the outcome of the vaccination failure, ophthalmic herpes zoster and blindness were unknown. It was unknown if the reporter considered the vaccination failure, ophthalmic herpes zoster and blindness to be related to Shingles vaccine. Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient got the shot a few years ago. Shortly afterward patient got shingles and they went into my eye. The patient was nearly blind in right eye. The reporter would not tell anyone not to get the shot but just be advised that it was possible to get shingles even if you have the shot. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.

Other Meds:

Current Illness:

ID: 1703360
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: got the shot, shingles / suspected vaccination failure; shingles; it hurts; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown. It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine. Additional case details were reported as follows: The reporter was patient's wife. The age at vaccination was not reported. The patient got the shot to but he had shingles and it hurts. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required

Other Meds:

Current Illness:

ID: 1703361
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: pain at injection site; This case was reported by a consumer via Shingrix GSK and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was not recovered/not resolved. It was unknown if the reporter considered the injection site pain to be related to Shingrix. Additional details provided were as follows: The case was reported by patient himself/herself. The age at vaccination was not reported. The patient received the 2nd dose of Shingrix vaccine and experienced pain at injection site. The patient was enquiring if he/she could take Tylenol or Ibuprofen to relieve pain at injection site. Follow-up would not be possible as no contact details available.

Other Meds:

Current Illness:

ID: 1703362
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: cellulitis; This case was reported by a consumer via other manufacturer and described the occurrence of cellulitis in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced cellulitis (serious criteria GSK medically significant). On an unknown date, the outcome of the cellulitis was unknown. The reporter considered the cellulitis to be related to Shingrix. Additional details were provided as follows: This case was reported by patients wife. The age at vaccination was not reported. The patient got cellulitis from Shingrix not at the injection site.

Other Meds:

Current Illness:

ID: 1703363
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: took the shots, shingles kept coming back/suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient took the 2 Shingles shots and the shingles kept coming back and coming back. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory confirmation of shingles were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1703365
Sex: F
Age:
State:

Vax Date:
Onset Date: 01/01/2021
Rec V Date: 09/16/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: got shingrix, small area on my forearm that blistered, would have gotten a lot worse without the shot / suspected vaccination failure; tingling nerve type pain; tingling; shut my arm DOWN; small area on my forearm that blistered; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included shingles (Family History) (husband had shingles on his ankle to knee and some on his thigh after Christmas last year). On an unknown date, the patient received Shingrix. In January 2021, less than 9 months after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, nerve pain, tingling and arm discomfort. On an unknown date, the outcome of the vaccination failure, nerve pain and arm discomfort were unknown and the outcome of the shingles was recovered/resolved and the outcome of the tingling was not recovered/not resolved. It was unknown if the reporter considered the vaccination failure, shingles, nerve pain, tingling and arm discomfort to be related to Shingrix. Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient got shingrix a couple of years ago before COVID showed up. The patient's husband had shingles on his ankle to knee and some on his thigh after Christmas last year. In January, patient had a small area on her forearm that blistered a bit. It lasted about 3 to 4 weeks but did not grow or hurt. The only thing the patient still had is a tingling nerve type pain that shoots down that arm from my shoulder. It happens sometimes 4 times a day and sometimes once a week. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule and laboratory test confirmation were unknown at the time of reporting. The follow up was not required.

Other Meds:

Current Illness:

ID: 1703366
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: suspected vaccination failure; the second time was light easier; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included shingles. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. The patient stated that, before receiving Shingles vaccine, shingles case was not good. After receiving Shingles vaccine, the patient got shingles. The patient stated that, Shingles vaccine helped. Shingles was light, easier and not as painful. This case was considered as suspected vaccination failure, since the details regarding the time to onset for event and laboratory confirmation of shingles were not provided. For the toleance of 1st dose, refer linked case US2021AMR192426. This was 1 of 3 linked cases, reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR192426:1st dose, same patient same reporter US-GLAXOSMITHKLINE-US2021AMR192711:Original Case : US2021AMR179087

Other Meds:

Current Illness:

ID: 1703367
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: had shingles vaccine, I got shingles / suspected vaccination failure; shingles; Shingles was just awful.; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included COVID-19 VACCINE (COVID19 VACCINE) for prophylaxis. The patient's past medical history included chickenpox (Had chickenpox when young). On an unknown date, the patient received Shingles vaccine and the 2nd dose of COVID19 VACCINE. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown. It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine. Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient had chickenpox when young. The patient had Shingles vaccine about 5 years before reporting and 3rd day after 2nd COVID19 vaccine, patient got a severe case of shingles on the same side of my vaccine. Shingles was just awful. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.

Other Meds:

Current Illness:

ID: 1703368
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: died twice and was brought back; had huge blisters all over me; have numerous scars.; This case was reported by a consumer via media and described the occurrence of near death experience in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Concurrent medical conditions included allergy. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced near death experience (serious criteria GSK medically significant and life threatening), blister and scar. On an unknown date, the outcome of the near death experience and blister were unknown and the outcome of the scar was not recovered/not resolved. It was unknown if the reporter considered the near death experience, blister and scar to be related to Shingles vaccine. Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient got the Shingles vaccine, took a reaction, died twice and was brought back, and had huge blisters all over and still had numerous scars. After receiving Tuberculosis (TB) vaccine, arm swelled up 3 times bigger and got blood poisoning. Twice after that when tested for employment at a hospital, the patient had the same reaction. Booster vaccine (unknown name vaccine) had to have it 3 times, scabbed up and arm became infected all 3 times. The patient have horrible allergies. The patient said not a fan of vaccines. No contact details were reported.

Other Meds:

Current Illness: Allergy

ID: 1703370
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Shingles and she had all the vaccines/suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included COVID-19 VACCINE (COVID-19 VACCINE UNKNOWN) for prophylaxis. The patient's past medical history included chickenpox (when the patient was young). On an unknown date, the patient received Shingles vaccine and the 2nd dose of COVID-19 VACCINE UNKNOWN. On an unknown date, unknown after receiving Shingles vaccine and an unknown time after receiving COVID-19 VACCINE UNKNOWN, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient had Shingles vaccine about 5 years ago from the date of reporting and 3rd day after 2nd COVID19 vaccine, the patient got a severe case of shingles on the same side of vaccine. The patient shingles was just awful. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation were unknown at the time of reporting. No contact details were available.

Other Meds:

Current Illness:

ID: 1703372
Sex: U
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Not the typical fainting and syncope; This case was reported by a nurse via call center representative and described the occurrence of syncope in an unspecified number of patients who received Men ACWY-CRM NVS (Menveo) for prophylaxis. On an unknown date, the patient received Menveo. On an unknown date, unknown after receiving Menveo, the patient experienced syncope (serious criteria GSK medically significant). The action taken with Menveo was unknown. On an unknown date, the outcome of the syncope was unknown. It was unknown if the reporter considered the syncope to be related to Menveo. Additional details were reported as follows: The age at vaccination was not applicable for this report. The reporter routinely administers Menveo and had the demonstrated wealth of experience with the vaccine. On 2nd August, the they began administering Menveo under a new lot number. The reporter stated that they were alarmed not only at the unusual high rate of adverse event but also the degree and severity of the adverse event where they had not previously witnessed before. These adverse events were documented in the product prescribing information and included over time after the product launch. There was no change in the health care professional administering Menveo and no change in the syringe or needle. The reporter stated that this had not just been your typical adverse reaction of syncope. The reporter had work within the immunization program for 7 years and had never seen these types of reactions. They had all been completely different than your typical fainting and syncope. This case is one of the 4 linked cases, reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021167017:Same reporter. Patient 1 atypical case. US-GLAXOSMITHKLINE-US2021AMR167723:Same reporter. Patient 2 atypical case. US-GLAXOSMITHKLINE-US2021AMR167724:Same reporter. Patient 3 atypical case.

Other Meds:

Current Illness:

ID: 1703375
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: shingles; This case was reported by a consumer via Shingrix GSK and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, several days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to Shingrix. Additional details were provided as follows: The case was reported by the consumer for himself/herself. The age at vaccination was not reported. The patient reported that, he/she had the Shingrix shot and within a few days the patient developed a few shingle spots. The patient asked was this normal.

Other Meds:

Current Illness:

ID: 1703376
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: second dose not administered; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose in 16th December 2020). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown. Additional information was provided as follow: The patient was the reporter. The age at vaccination was not applicable for this report. Till the time of reporting patient did not receive 2nd dose of Shingrix vaccine, which led to incomplete course of vaccination. The patient had asked for advice.

Other Meds:

Current Illness:

ID: 1703377
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: first shot years ago, late second dose; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 67-year-old patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose on an unknown date about 5 years ago). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown. Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not applicable for this report. The patient reported that he/ she had received first shot about 5 years ago but never had the second dose, which led to incomplete course of vaccination. The patient enquired if they needed to start over.

Other Meds:

Current Illness:

ID: 1703378
Sex: F
Age:
State: CT

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Flu-like symptoms; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Flu shot (patient received yearly flu shot) and Shingrix with an associated reaction of influenza like illness (patient received 1st dose on an unknown date in 2019 and experienced flu-like symptoms, refer linked case US2021192908). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced influenza-like symptoms. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved. The reporter considered the influenza-like symptoms to be related to Shingrix. Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported but it could be 57 or 58 years old. Two years before the reporting date, the patient had got the Shingix two-shot series and experienced flu-like symptoms for a couple of days. The patient stated that the side effects were expected and had recovered after a day or so. The patient did not specify if side effects occurred after dose 1 or dose 2 or both. The patient did not consent to follow-up and did not want to provide Medical doctor contact information. This case has been linked to US2021AMR193164 and US2021192911, reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021192908:same reporter,same patient, same suspect, different dose (1st dose) US-GLAXOSMITHKLINE-US2021AMR193164:same reporter US-GLAXOSMITHKLINE-US2021192911:same reporter

Other Meds:

Current Illness:

ID: 1703380
Sex: M
Age:
State: CT

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: flu-like symptoms; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 64-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Flu shot (patient received yearly flu shot) and Shingrix with an associated reaction of influenza like illness (patient received 1st dose on an unknown date and experienced flu-like symptoms, refer linked case US2021192911). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced influenza-like symptoms. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved. The reporter considered the influenza-like symptoms to be related to Shingrix. Additional details were provided as follows: The reporter was the patient's wife. The age at vaccination was not reported but it could be 61 or 62 years old. Two years before the reporting date, the patient had got the Shingix two-shot series and experienced flu-like symptoms for a couple of days. The reporter stated that the side effects were expected and had recovered after a day or so. The reporter did not specify if side effects occurred after dose 1 or dose 2 or both. The reporter did not consent to follow-up and stated that she was certain that her husband did not want GlaxoSmithKline to contact his doctor. This case has been linked to US2021AMR193160 and US2021192908, reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021192911:same reporter,same patient, same suspect, different dose (1st dose) US-GLAXOSMITHKLINE-US2021192908:same reporter US-GLAXOSMITHKLINE-US2021AMR193160:same reporter

Other Meds:

Current Illness:

ID: 1703382
Sex: F
Age: 30
State: PA

Vax Date: 09/03/2021
Onset Date: 09/10/2021
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data: N/a

Allergies: Yeast, Soy, Mold

Symptom List: Injection site pain

Symptoms: Aside from heavy/ sore arm low grade fever and change in appetite, I experienced post menstruated bleeding around the 10th of September until currently. I am also on birth control, this bleeding has been daily and enough to change a panty liner with every time I use the rest room.

Other Meds: Birth control.

Current Illness: None.

ID: 1703384
Sex: F
Age: 67
State: NY

Vax Date: 09/15/2021
Onset Date: 09/15/2021
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies: //

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: injection site pain left arm pain feverish

Other Meds: //

Current Illness: //

ID: 1703385
Sex: F
Age: 51
State: TX

Vax Date: 07/16/2021
Onset Date: 07/01/2021
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Headaches; Chills; Feverish; Weak; Light was bothering her; Sound was bothering her; No appetite; Started feeling bad next day; This case was reported by a other health professional via sales rep and described the occurrence of headache in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 16th July 2021, the patient received the 1st dose of Shingrix. In July 2021, less than a day after receiving Shingrix, the patient experienced headache, chills, fever, weakness, photophobia, sound sensitivity increased, appetite absent and feeling bad. The patient was treated with hydrocodone. On an unknown date, the outcome of the headache, chills, fever, weakness, photophobia, sound sensitivity increased, appetite absent and feeling bad were recovering/resolving. It was unknown if the reporter considered the headache, chills, fever, weakness, photophobia, sound sensitivity increased, appetite absent and feeling bad to be related to Shingrix. Additional details were provided as follows: The patient was vaccinated with Shingrix in the pharmacy and experienced headaches, chills, felt feverish, weak, light and sound was bothering her and had no appetite. The patient started feeling bad the next day, less than 24 hours after vaccination. The patient took a hydrocodone to make herself feel better. The symptoms lasted through next day after vaccination, but patient felt better 2 days later. The reporter consented to follow-up.

Other Meds:

Current Illness:

ID: 1703386
Sex: U
Age:
State:

Vax Date: 09/08/2021
Onset Date: 09/08/2021
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Arm pain; This case was reported by a consumer interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2020-2021 season) for prophylaxis and COVID-19 VACCINE (COVID 19 VACCINE) for prophylaxis. On 8th September 2021, the patient received Shingles vaccine, Influenza vaccine Quadrivalent 2020-2021 season and the 3rd dose of COVID 19 VACCINE. On 8th September 2021, less than a day after receiving Shingles vaccine and Influenza vaccine Quadrivalent 2020-2021 season, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved. It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine and Influenza vaccine Quadrivalent 2020-2021 season. Additional details were reported as follows: This case was reported by the patient for herself/himself. The age at vaccination was not reported. On the date of reporting, the patient got the Covid shot, flu shot and shingles shot and mentioned that arm hurts. The contacts details were not reported hence follow up not possible. It was unknown if the reporter considered the pain in arm to be related to Covid shot.

Other Meds:

Current Illness:

ID: 1703387
Sex: U
Age:
State:

Vax Date: 09/07/2021
Onset Date: 09/08/2021
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Swollen gland under my arm that received the shot; Achy; Tired; Slight headache; This case was reported by a consumer via (Shingrix GSK Chatbot) interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingrix) for prophylaxis. On 7th September 2021, the patient received the 1st dose of Shingrix. On 8th September 2021, 1 days after receiving Shingrix, the patient experienced pain, tiredness and headache. On 9th September 2021, the patient experienced axillary lymph nodes enlarged. On an unknown date, the outcome of the pain, tiredness and headache were recovering/resolving and the outcome of the axillary lymph nodes enlarged was not recovered/not resolved. It was unknown if the reporter considered the pain, tiredness, headache and axillary lymph nodes enlarged to be related to Shingrix. Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The patient received vaccine two days before the reporting date and felt achy, tired and had a slight headache one day after vaccination. On the morning of the reporting date, the patient woke up feeling better but had a swollen gland under their arm that received the shot. The patient was asking if this was a normal reaction.

Other Meds:

Current Illness:

ID: 1703388
Sex: F
Age:
State: PA

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: suspected vaccination failure; shingles; This case was reported by a consumer via other manufacturer and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included disability. On an unknown date, the patient received Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovered/resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix. Additional details were provided as follows: The patient received the Shingrix, about a year ago from the date of reporting. The age at vaccination not reported. She mentioned that, it did not work it was a total placebo. After receiving Shingrix, the patient had the shingles for about a year and she described it as the worst shingles that she had ever had. The patient had gotten the shingles vaccinations since they became available and they had always worked on her. She spent on the vaccine and did not cover it, she paid for it and it did not work at all. She would keep receiving a replacement, another inoculation at no charge since the one she got did not work. The patient was given PMI phone number, reporter also said she had a vocal disability. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1703389
Sex: F
Age:
State:

Vax Date: 09/08/2021
Onset Date: 09/09/2021
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: tiredness; fever; stomach; This case was reported by a consumer via (Shingrix interactive digital media and described the occurrence of tiredness in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. On 8th September 2021, the patient received Shingrix. On 9th September 2021, 1 days after receiving Shingrix, the patient experienced tiredness, fever and stomach pain. On an unknown date, the outcome of the tiredness, fever and stomach pain were unknown. It was unknown if the reporter considered the tiredness, fever and stomach pain to be related to Shingrix. Additional details provided were as follows: The reporter was the daughter of the patient. Age at vaccination was not reported. The patient received the the Shingrix shot and at the time of reporting experienced the common side effects of tiredness, stomach, and fever. The reporter asked how long will these side effects will last. Follow-up would not be possible as no contact details available.

Other Meds:

Current Illness:

ID: 1703390
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: supposed to have #2 around Apr 2020 but did not due to covid; This case was reported by a consumer via call center representative and described the occurrence of social problem in a 38-year-old patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose on an unknown date in December 2019). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown. Additional details were provided as follows: The patient-self reported this case. The age at vaccination was not applicable for this report. The patient was about to receive the second dose around April 2020, but did not due to covid. The patient enquired if he/she could take the second dose and if it would be effective.

Other Meds:

Current Illness:

ID: 1703391
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included chickenpox (as a child). On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovered/resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles, but it was very mild and resolved quickly. The patient was glad to get the Shingles vaccine. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1703393
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. The reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles. The patient stated that, Shingles vaccine could give shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1703394
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included shingles (twice). On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles again. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1703395
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included COVID-19 VACCINE for prophylaxis. On an unknown date, the patient received Shingles vaccine and COVID-19 VACCINE. On an unknown date, several years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The case was reported for the reporter's mother. The age at vaccination was not reported. The patient received Shingles vaccine, several years ago from the date of reporting. Recently the patient received Covid vaccine and a week later, the patient got shingles. It was unknown if the reporter considered the shingles to be related to COVID-19 VACCINE. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1703396
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: suspected vaccination failure; contracted Shingles; still hurts of the nerve line it traveled.; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and post herpetic neuralgia. On an unknown date, the outcome of the vaccination failure and shingles were unknown and the outcome of the post herpetic neuralgia was not recovered/not resolved. The reporter considered the vaccination failure, shingles and post herpetic neuralgia to be related to Shingles vaccine. Additional details were provided as follows: The reporter was the patient's friend. The age at vaccination was not reported. The reporter got shingles twice, not as bad last time but it was close to one eye. The reporter did not trust Shingles vaccine after the patient contracted shingles from Shingles vaccine. After many years till the time of reporting, it still hurt of the nerve line it travelled. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1703397
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: suspected vaccination failure; get them; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included shingles. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The case was reported for the reporter's mother. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1703399
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: suspected vaccination failure; shingles; ill; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and unwell. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles and unwell were recovered/resolved. It was unknown if the reporter considered the vaccination failure, shingles and unwell to be related to Shingles vaccine. Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient became ill with shingles. The patient's recovery time was lengthy of many many months. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1703400
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1703401
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. The patient was treated with antivirals nos (Antiviral (Drug Name Unknown)). On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient still got shingles. The patient stated that, it did not prevent shingles, it kept the break outs becoming too aggressive. Till the time of reporting, the patient still had to get the antiviral upon the first days. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1703402
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: suspected vaccination failure; had it; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles twice. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1703403
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: vaccine for shingles, After the covid vaccine I got Shingles/suspected vaccination failure; I got Shingles.; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included COVID-19 VACCINE for prophylaxis. The patient's past medical history included chickenpox (had in 3rd grade). On an unknown date, the patient received Shingles vaccine and COVID-19 VACCINE. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient got Shingles and after the covid vaccine, the patient got the shingles. On an unknown date, unknown after receiving Covid 19 vaccine, the patient experienced shingles. It was unknown if the reporter considered the shingles to be related to Covid 19 vaccine. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1703404
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: got vaccinated and still have gotten shingles/suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient got the vaccinated with Shingles and still had got shingles 4 times. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am